ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

Funding Opportunities (12-page issue).

May 16, 2003

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

NCI Gets Concept Approval for New Communications Network

May 27, 1988

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012